Biopharmaceutical CMO & CRO Market Size, Share, Growth Analysis, By Source(Mammalian, Non-mammalian), By Service(Contract Manufacturing (Process Development, Downstream, Upstream, Fill & Finish Operations), By Product(Biologics (Monoclonal antibodies (MAbs), Recombinant Proteins, Vaccines, Antisense), By Region - Industry Forecast 2024-2031

Because of the presence of a significant number of established as well as medium- to small-sized CMOs and CROs, the market is fragmented. Several market players are privately held or are part of the portfolios of private equity companies. CMOs are incorporating automation and cutting-edge technology into their factories to boost project productivity and product quality. This has fueled big molecule producers' interest in CMOs to address the increased demand for biologics. Charles River Laboratories International, Inc.; PRA Health Sciences; ICON plc. Pharmaceutical Product Development, LLC; LabCorp; and Parexel International Corporation are engaged in offering contract research services for large molecule production. Market players focus on various business strategies including mergers, acquisitions, product launches, etc. For instance, in December 2021, Discovery Life Sciences completed and announced the acquisition of In Vitro ADMET Laboratories (IVAL). With this move, the company aims to expand its skilled workforce allowing them to competently cater to the rising outsourcing of research activities. Cerba HealthCare made a public statement in December 2021 on its acquisition of the Viroclinics-DDL company. With this, it has joined the CRO industry, with a focus on precision medicine for auto-immune illnesses. Lonza issued a news statement in November 2021 announcing the acquisition of the Exosomics Service Unit. This will increase its future potential to generate and manufacture exosomes.

Biopharmaceutical CMO & CRO Market Top Player's Company Profiles

• Lonza Group AG
• Catalent, Inc.
• Thermo Fisher Scientific Inc.
• Patheon N.V.
• WuXi AppTec Co., Ltd.
• Samsung Biologics
• Boehringer Ingelheim GmbH
• Cytovance Biologics, Inc.
• AbbVie Contract Manufacturing
• Fujifilm Diosynth Biotechnologies
• AGC Biologics
• AMRI Global
• Charles River Laboratories International, Inc.
• Evotec SE
• PAREXEL International Corporation
• Syneos Health, Inc.
• ICON plc
• PRA Health Sciences, Inc.
• IQVIA Holdings Inc.
• LabCorp

Biopharmaceutical CMO & CRO Market